↓ Skip to main content

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, September 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom
Published in
Allergy, Asthma & Clinical Immunology, September 2013
DOI 10.1186/1710-1492-9-33
Pubmed ID
Authors

Johanna Stoevesandt, Bernd Hofmann, Johannes Hain, Andreas Kerstan, Axel Trautmann

Abstract

Referring to individuals with reactivity to honey bee and Vespula venom in diagnostic tests, the umbrella terms "double sensitization" or "double positivity" cover patients with true clinical double allergy and those allergic to a single venom with asymptomatic sensitization to the other. There is no international consensus on whether immunotherapy regimens should generally include both venoms in double sensitized patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Turkey 1 4%
Canada 1 4%
Unknown 26 93%

Demographic breakdown

Readers by professional status Count As %
Other 4 14%
Professor > Associate Professor 4 14%
Student > Bachelor 3 11%
Researcher 3 11%
Student > Master 3 11%
Other 5 18%
Unknown 6 21%
Readers by discipline Count As %
Medicine and Dentistry 15 54%
Agricultural and Biological Sciences 5 18%
Physics and Astronomy 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 6 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2013.
All research outputs
#17,286,645
of 25,374,917 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#668
of 924 outputs
Outputs of similar age
#132,116
of 210,224 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#8
of 10 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 924 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,224 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.